Our expert for hiPSC-derived cardiac cells, as well as cell-based assays & services for drug safety and efficacy screenings
Ncardia supplies human iPSC-derived cardiomyocytes optimized for use with the Maestro MEA System. Together these technologies enable detailed electrophysiological detection of potential cardioactive and proarrhythmic effects of test compounds in 48- and 96-well plate formats. The result is a highly relevant in vitro assay platform for studying cardiac safety or efficacy profile of compounds during drug development.
Case studies were performed to assess the effects of cardioactive compounds on the electrophysiology of Pluricyte Cardiomyocytes using the Maestro MEA system. Pluricyte Cardiomyocytes show the expected pharmacological responses to reference compounds in a reproducible manner.